文献速递妇科

探究卵巢癌检测的危害——有卵巢癌症状女性的心理结局与癌症转化率:嵌入多中心ROCkeTS前瞻性诊断研究的队列研究

Investigating harms of testing for ovarian cancer - psychological outcomes and cancer conversion rates in women with symptoms of ovarian cancer: A cohort study embedded in the multicentre ROCkeTS prospective diagnostic study.
PubMed 文献 · BJOG · 2024-03-31

本研究为嵌入多中心ROCkeTS前瞻性诊断研究的单臂前瞻性队列,纳入2596例CA125升高或影像异常的新发有症状女性,评估焦虑与痛苦水平及12个月变化,并报告按年龄、绝经状态和转诊路径的卵巢癌转化率。结果显示招募时52.1%和68.6%分别有中重度痛苦和焦虑,12个月时76%受访者焦虑痛苦等级不变或加重;<40岁卵巢癌率1.6%,≥40岁10.9%。

要点

  • 招募时52.1%有中重度痛苦,68.6%有焦虑,年轻和急诊就诊者痛苦更高。
  • 12个月时76%受访者焦虑痛苦等级不变或加重,尽管未诊断癌症。
  • 卵巢癌率<40岁1.6%(95%CI 0.5%-5.9%),≥40岁10.9%(95%CI 8.7%-13.6%)。

核心结论

  • 接受诊断检测的女性表现出严重焦虑和痛苦,年轻女性尤其脆弱,应作为支持目标;40岁以下女性转化率低,作者主张减少该组检测以减少检测危害。

研究设计与样本

  • 单臂前瞻性队列研究,嵌入多中心ROCkeTS前瞻性诊断研究,纳入2596例新发有症状且CA125升高或影像异常或两者的女性。

主要发现

  • 招募时1355/2596(52.1%)经历中重度痛苦,1781/2596(68.6%)经历焦虑。
  • 年轻年龄和急诊就诊者痛苦水平更高。
  • 12个月时76%受访者焦虑和痛苦的临床分类保持不变或恶化,尽管未诊断癌症。
  • 卵巢癌率按年龄:<40岁1.6%(95%CI 0.5%-5.9%),≥40岁10.9%(95%CI 8.7%-13.6%)。
  • 快速通道转诊中,绝经前卵巢癌率3.3%(95%CI 1.9%-5.7%),绝经后18.5%(95%CI 16.1%-21.0%)。

临床怎么用

  • 作者认为年轻女性尤其脆弱应作为支持目标,并主张减少40岁以下女性的检测以减少检测危害。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate psychological correlates in women referred with suspected ovarian cancer via the fast-track pathway, explore how anxiety and distress levels change at 12 months post-testing, and report cancer conversion rates by age and referral pathway. DESIGN: Single-arm prospective cohort study. SETTING: Multicentre. Secondary care including outpatient clinics and emergency admissions. POPULATION: A cohort of 2596 newly presenting symptomatic women with a raised CA125 level, abnormal imaging or both. METHODS: Women completed anxiety and distress questionnaires at recruitment and at 12 months for those who had not undergone surgery or a biopsy within 3 months of recruitment. MAIN OUTCOME MEASURES: Anxiety and distress levels measured using a six-item short form of the State-Trait Anxiety Inventory (STAI-6) and the Impact of Event Scale - Revised (IES-r) questionnaire. Ovarian cancer (OC) conversion rates by age, menopausal status and referral pathway. RESULTS: Overall, 1355/2596 (52.1%) and 1781/2596 (68.6%) experienced moderate-to-severe distress and anxiety, respectively, at recruitment. Younger age and emergency presentations had higher distress levels. The clinical category for anxiety and distress remained unchanged/worsened in 76% of respondents at 12 months, despite a non-cancer diagnosis. The OC rates by age were 1.6% (95% CI 0.5%-5.9%) for age <40 years and 10.9% (95% CI 8.7%-13.6%) for age ≥40 years. In women referred through fast-track pathways, 3.3% (95% CI 1.9%-5.7%) of pre- and 18.5% (95% CI 16.1%-21.0%) of postmenopausal women were diagnosed with OC. CONCLUSIONS: Women undergoing diagnostic testing display severe anxiety and distress. Younger women are especially vulnerable and should be targeted for support. Women under the age of 40 years have low conversion rates and we advocate reducing testing in this group to reduce the harms of testing.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Kwong FL, Kristunas C, Davenport C, et al. Investigating harms of testing for ovarian cancer - psychological outcomes and cancer conversion rates in women with symptoms of ovarian cancer: A cohort study embedded in the multicentre ROCkeTS prospective diagnostic study. BJOG. 2024. PMID: 38556698. doi:10.1111/1471-0528.17813

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。